|
|
Other links at Articles > Business of Medicine |
| 4. |
New FDA Orphan Drugs: AVI-4658, SQ109, ATIR
|
|
|
The FDA has granted orphan drug designation to AVI-4658 for the treatment of Duchenne muscular dystrophy, SQ109 for the treatment of tuberculosis, and ATIR for the topical treatment of graft-versus-host disease. Medscape Medical News
|
|
|